Sign in
IRLA Stock Price, Chart, Stats & News
IRulya Therapeutics Inc.
Save
IRulya Therapeutics Inc. (IRLA) does not currently pay a dividend.
35.04M
Market cap
–
Current P/E
–
Forward P/E
IRLA chart
About
IRulya Therapeutics is a clinical-stage biopharmaceutical company developing LAM-001, an inhaled formulation of rapamycin, for pulmonary diseases.
Similar securities
Based on sector and market capitalization
Report issue